• 4-Week Delivery: World’s fastest custom mouse model development.
  • TurboMice™ Tech: Proprietary high-efficiency gene-editing platform.
  • Full Capabilities: Expert conditional knockouts, knock-ins, and humanized models.
  • Validated Quality: Guaranteed high precision and model viability.
Partners' Projects

Ldlr KO Mouse Model

Category Tag
Strain Name

Ldlr KO Mouse Model (M10014)

Editing Type

Knockout

Gene Name

Ldlr (mouse low density lipoprotein receptor)

Gene Synonyms

Hlb301

Strain Background

C57BL/6N

NCBI No.

Gene ID: 16835 / MGI:96765

1. Atherosclerosis and cardiovascular disease Investigating how LDLR (low density lipoprotein receptor) deficiency impairs plasma LDL clearance, producing severe hypercholesterolemia and spontaneous atherosclerotic plaque formation; under high-fat feeding such as a Western diet, accelerating lesion progression and evaluating lipid-lowering drugs (statins, PCSK9 inhibitors), anti-inflammatory agents and novel interventions.

2. Lipid metabolism and liver pathophysiology Exploring the central role of LDLR in hepatic lipid uptake, metabolism and cholesterol homeostasis, and its influence on the development of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis.

3. Metabolic syndrome Assessing the impact of LDLR deficiency on systemic lipid dysregulation, insulin resistance and obesity-related metabolic abnormalities.

This mouse strain is generated by gene targeting to knock out the low density lipoprotein receptor (Ldlr) gene. LDLR is the primary receptor through which the liver clears low density lipoprotein (LDL) from the circulation, and loss of its function leads to markedly elevated plasma LDL cholesterol. Unlike ApoE KO mice, Ldlr KO mice develop only moderate hypercholesterolemia on a normal chow diet; when fed a high-fat/high-cholesterol diet such as a Western diet, they rapidly and consistently develop severe hypercholesterolemia and extensive atherosclerotic lesions. The progression and pathological features of these lesions — lipid cores, fibrous caps, inflammatory cell infiltration — closely resemble human atherosclerosis and can be modulated by dietary intervention. The Ldlr KO mouse has therefore become one of the most important and widely used models for studying lipid metabolism, the pathogenesis of atherosclerosis and the efficacy of lipid-lowering and anti-atherosclerotic drugs.

  1. A diet switch you control. Moderate hypercholesterolemia on chow, severe disease on a Western diet — the onset of atherosclerosis becomes an experimental variable rather than a fixed background, which is what makes intervention studies interpretable.
  2. Lesions that look like human ones. Lipid cores, fibrous caps and inflammatory infiltration are all present, so plaque histology can be read against human pathology instead of against a surrogate.
  3. A validated drug-testing platform. Statins, PCSK9 inhibitors and anti-inflammatory agents all have established readouts here; this is the field’s standard model for lipid-lowering efficacy.
  4. Liver arm included. Hepatic lipid uptake and cholesterol homeostasis are measurable in the same animal, covering the NAFLD and fibrosis side of the story.
  5. A clean C57BL/6N background. Suitable for crossing to ApoE, humanized or reporter lines without carrying a second spontaneous mutation.

FAQ

Game-changing benefits?

While competitors highlight germline efficiency gains, shorter timelines and enhanced 3Rs animal welfare benefits for their technologies, these are merely incremental improvements over traditional approaches. In sharp contrast, our proprietary technology delivers fully pure, homogeneous lineages—every single cell of the mice is derived exclusively from totipotent ES cells, with guaranteed 100% germline transmission efficiency. To experience these unparalleled benefits firsthand, enquire about your custom mouse model project with us or order embryos for in-house validation at your facility.

•Free initial design proposal with zero obligations.​
•Request a free quote!

All model generation projects of Mingceler operate under a fee-for-service framework.
IP Ownership: All intellectual property rights related to custom mouse models, including derived organs, tissues, cells, and biological materials, are the sole and exclusive property of the Client.
Third-Party Transfer Permission: The Client may independently decide to retain, utilize, or commercialize their custom models project materials (e.g., targeting vectors, ES cells, mouse lines) without the need for prior consent from Mingceler.
Licensing Exemption: The Client has full autonomy over all uses of the custom models or their derivatives, including but not limited to commercialization, distribution to third parties, and publication involving model data. No written license from Mingceler is required for such uses.

This website uses cookies

We use cookies to personalize content, provide social media features, and analyze our traffic. We also share information about your use of our site with our analytics partners. You can change your preferences at any time. For more information, please see our Privacy Policy Cookie Policy